Viatris Inc.

XNASHealth care

Last traded price · USD

$19.44

+2.72%Market closed

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 06:23 IST · A quote does not mean the product is available to trade on your account.

Day's open: $19.33
Previous close: $18.92
Volume: 8.4M
Day's high: $19.33
Day's low: $18.71

In brief

Viatris Inc. is a health care company listed on Nasdaq, valued at about $22.32B.
Its shares closed at $19.22 on 4 Nov 2026, up 83.2% over the past year.
From India you can buy VTRS in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Viatris Inc. (VTRS) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole VTRS share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade VTRS options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

1.5% below its 52-week high
Closed at $19.22 on 4 Nov 2026: 1.5% below the 52-week high of $19.51 (30 Oct 2026) and 93.8% above the low of $9.92 (7 Nov 2025).
Daily price bars, split-adjusted · as of 4 Nov 2026
Ahead of SPY and its sector fund XLV over 1 year
1 month: +9.6% (SPY −1.6%, XLV +13.5%). 3 months: +8.9% (SPY −0.4%, XLV +15.5%). 1 year: +83.2% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: VTRS, SPY and XLV · as of 4 Nov 2026
Above its 50- and 200-day averages
The 4 Nov 2026 close of $19.22 was 9.2% above its 50-day average ($17.60) and 20.2% above its 200-day average ($15.99). It has closed above the 200-day for 277 sessions, since 30 Sep 2025. The 50-day average crossed above the 200-day on 24 Sep 2025, 280 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Short interest at 3.3% of shares outstanding
37.9M shares were sold short at the 15 Oct 2026 settlement, 3.3% of the 1.15B shares outstanding; covering them would take 4.6 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+9.6%

6 months+20.5%

1 year+83.2%

5 years+40.5%

Newswire

About

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up one-third of Viatris' total sales. The remaining sales are derived from its portfolio of legacy products, including Lipitor, Norvasc, Lyrica, and Viagra.

Website

Notable moves

February 27, 2025
−15.21%
November 7, 2024
+13.52%
February 28, 2022
−24.28%

Viatris Inc.

XNASHealth care

Last traded price · USD

$19.44

+2.72%Market closed

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 06:23 IST · A quote does not mean the product is available to trade on your account.

Day's open: $19.33
Previous close: $18.92
Volume: 8.4M
Day's high: $19.33
Day's low: $18.71

In brief

Viatris Inc. is a health care company listed on Nasdaq, valued at about $22.32B.
Its shares closed at $19.22 on 4 Nov 2026, up 83.2% over the past year.
From India you can buy VTRS in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Viatris Inc. (VTRS) shares from India?

Do I need the price of a whole VTRS share to invest?

How much can I invest in US stocks in a year?

Can I trade VTRS options or futures?

Insights

Quotes run fifteen minutes behind.

1.5% below its 52-week high
Closed at $19.22 on 4 Nov 2026: 1.5% below the 52-week high of $19.51 (30 Oct 2026) and 93.8% above the low of $9.92 (7 Nov 2025).
Daily price bars, split-adjusted · as of 4 Nov 2026
Ahead of SPY and its sector fund XLV over 1 year
1 month: +9.6% (SPY −1.6%, XLV +13.5%). 3 months: +8.9% (SPY −0.4%, XLV +15.5%). 1 year: +83.2% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: VTRS, SPY and XLV · as of 4 Nov 2026
Above its 50- and 200-day averages
The 4 Nov 2026 close of $19.22 was 9.2% above its 50-day average ($17.60) and 20.2% above its 200-day average ($15.99). It has closed above the 200-day for 277 sessions, since 30 Sep 2025. The 50-day average crossed above the 200-day on 24 Sep 2025, 280 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Short interest at 3.3% of shares outstanding
37.9M shares were sold short at the 15 Oct 2026 settlement, 3.3% of the 1.15B shares outstanding; covering them would take 4.6 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+9.6%

6 months+20.5%

1 year+83.2%

5 years+40.5%

Newswire

About

Website

Notable moves

February 27, 2025
−15.21%
November 7, 2024
+13.52%
February 28, 2022
−24.28%

Viatris Inc.

Viatris Inc. in brief

1.5% below its 52-week high

Ahead of SPY and its sector fund XLV over 1 year

Above its 50- and 200-day averages

Short interest at 3.3% of shares outstanding

Viatris Inc.

Viatris Inc. in brief

1.5% below its 52-week high

Ahead of SPY and its sector fund XLV over 1 year

Above its 50- and 200-day averages

Short interest at 3.3% of shares outstanding